Navigation Links
Haemonetics Sets Date for Investor/Analyst Meeting
Date:4/24/2013

BRAINTREE, Mass., April 24, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Thursday, May 16th from 10:00 am to 3:00 pm at The Seaport Hotel in Boston, Massachusetts.

(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO)

The agenda for the meeting includes updates on the following:

  • Hospital Based Blood Management Solutions / Emerging Markets
  • R&D Update Including Automated Whole Blood, OrthoPAT® Advance™ and Future New Products
  • Commercial Value Creation & Capture (" VCC")
  • Operations Overview and Strategy
  • Guidance and Aspirational Goals

The meeting is open to analysts, shareholders, and others in the investment community by invitation. Invitations will follow shortly and attendees must register by May 3rd. On-line registration will be utilized and instructions for registration will accompany invitations.

Other audiences are welcome to participate in the meeting via live webcast. Webcast details are posted on the following link:  http://www.media-server.com/m/p/64xj58en.  For more information, please contact Bryanne Salmon at (781) 356-9613 or bsalmon@haemonetics.com.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT: Investor Relations
Gerry Gould (781) 356-9402
gerry.gould@haemonetics.com
Bryanne Salmon (781) 356-9613                                                                                                 bsalmon@haemonetics.com  


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
2. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
3. Haemonetics Completes Acquisition of Palls Transfusion Medicine Business
4. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
5. Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
6. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
7. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
8. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
9. Stereotaxis Epoch™ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
10. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
11. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 3, 2016   BIOTRONIK , a leader ... Food and Drug Administration (FDA) approval of Iperia ... heart failure patients with access to diagnostic magnetic ... remote monitoring with daily automatic transmission and closed ... in response to physiological demands. ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK will ... extending care beyond the implant at the Heart Rhythm ... in San Francisco . ... the highest quality of patient care and satisfaction possible. ... for each and every tomorrow," said Marlou Janssen ...
(Date:5/3/2016)... , May 3, 2016 Pharmaceutical ... $55 million to a woman who says its talc-based ... awarded Gloria Ristesund $5 million in compensatory ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... against the company. In February, the same court awarded ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... 06, 2016 , ... Innovations with Ed Begley Jr. announced ... 2016, via Discovery Channel. Dates and show times TBA. , AsedaSciences® was established ... through innovative cellular analysis. In this segment, viewers will learn how AsedaSciences utilizes ...
(Date:5/6/2016)... , ... May 06, 2016 , ... From May 4 ... IL, offering EarQ members the unique opportunity to learn more about Signia’s technology and ... practice growth. , “It is our priority to see practices succeed in this highly ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... Sleepopolis.com . , Since launching in September, 2014 Sleepopolis has resided at ... areas, which now include pillows, sheets, mattress toppers, bed frames, and more. , ...
(Date:5/6/2016)... ... May 06, 2016 , ... In honor of Military Spouse ... training, and the National Military Family Association, a nonprofit that works to strengthen ... full-tuition scholarship recipient of 2016. , “Being awarded this scholarship by Career ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... President at CareFirst Blue Cross BlueShield and Former Principal Deputy Administrator at Centers ... - an Anthem Company; Steve Ondra, MD, Chief Medical Officer at Health Care ...
Breaking Medicine News(10 mins):